Jyothy Labs Q4 FY26: Volume growth, margin pressure

Jyothy Labs ended Q4 FY26 with steady top-line momentum but a clear squeeze on profitability. Revenue from operations grew 7.7% year-on-year to INR 717 crore, supported by a 10.8% volume increase. The pressure point was margins. Gross margin fell to 45.2% from 49.2% last year, and operating EBITDA margin declined to 13.5% from 16.8%. Profit after tax came in at INR 67.5 crore, down 12.3%.

For the full year FY26, revenue reached INR 2,944 crore, up 3.5%, while volumes grew 6%. EBITDA stood at INR 449.9 crore, and PAT was INR 333.2 crore. The company’s narrative through both the investor deck and the earnings call was consistent: demand held up better in the second half, but inflation in crude-linked inputs and packaging tightened the profit pool.

The operating backdrop: stable demand, rising input costs

Management described FY26 as a volatile year for FMCG, with uneven urban demand for much of the year and stronger traction in H2. Rural markets were relatively resilient, aided by monsoons and government spending. The bigger swing factor was cost. The company highlighted that 50% to 60% of inputs are crude-linked directly or indirectly, and packaging costs account for roughly 15% to 20% of material costs.

In Q4, the West Asia situation pushed crude higher, and management said this flowed into key inputs and packaging materials. The company also indicated there is usually a two to three month lag between cost increases and pricing actions. That lag, combined with competitive price-offs and higher grammage in some categories, weighed on realizations and gross margin.

Category performance: Fabric Care leads, Dishwash fights it out

Fabric Care remained the growth engine. In Q4 FY26, Fabric Care grew 14.4% in value terms. Management called out strong momentum across both main wash and post wash, and reiterated that liquid detergents continued to scale. In FY26, Fabric Care grew 8.1% in value terms, and the call noted Fabric Care volumes were up 9.5% for the year, led by liquid detergents that “nearly doubled”.

Dishwash was the most competitive segment. Q4 FY26 value growth was flat at 0.1% even as volumes grew, which management attributed to price reductions, higher grammage and promotional activity across the market. For FY26, Dishwash revenue declined 1.3% despite a stated 6% volume growth, again pointing to intense competition.

Personal Care showed a notable recovery in Q4. The segment grew 20.1% in Q4 FY26, and FY26 growth was 5.2%. Management attributed the improved trajectory to demand stabilising after GST-related disruption earlier in the year and highlighted the Margo franchise as a key contributor.

Household Insecticides was positioned as a turnaround-in-progress. While the category declined 1.3% in FY26 and grew 3.0% in Q4, management said the focus has been on reducing losses and improving mix. Losses were stated to have reduced from about INR 25 crore in FY25 to about INR 5 crore in FY26.

What management is doing: innovation, mix, and calibrated pricing

On innovation, the company highlighted multiple launches and portfolio actions across categories. In Fabric Care, management referenced Dr. Wool liquid detergent and continued portfolio development in Ujala, Mr. White and Morelight, with an emphasis on building liquids and maintaining visibility and distribution.

In Dishwash, Exo was supported with a bio-enzyme based proposition across formats, and Exo Liquid was positioned as a mass-market complement to Pril, which remains focused on premium liquid dishwash and leadership in modern trade and e-commerce.

In Household Insecticides, the company’s strategy is to increase the share of liquid vaporizers and newer formats. Management said the mix has improved, with liquid vaporizers now about 55% of the portfolio versus 50% last year. They also referenced newer products like aerosol and racquet formats, which they said are profitable relative to coils.

The second lever is pricing. The CFO stated that pricing action to the tune of about 4% at the portfolio level was taken in March, with impact expected largely in Q1 FY27 and full impact by Q2 FY27. However, management emphasised that full pass-through is difficult in the near term, particularly in low unit packs where price points are fixed and demand elasticity matters.

Balance sheet and operating discipline

Jyothy Labs ended FY26 with a stronger cash position and improved working capital versus the prior year. Cash balance stood at INR 997 crore as of March 2026, up from INR 757 crore in March 2025. Operating working capital was reported at 15 days versus 19 days last year. The company reiterated that it remains debt free.

At the same time, returns moderated. ROE declined to 21.0% in Mar-26 from 26.8% in Mar-25, and EPS was INR 9.07 compared with INR 10.11 in the prior year. The margin cycle and inflation shock were key drivers of this decline.

The near-term setup: volumes first, margins later

Management’s FY27 commentary was cautious. The company said it will prioritise growth over margins in the near term and expects margins to remain subdued given the limited ability to pass on full inflation immediately. It also noted that further price increases may be taken depending on how crude-linked inflation and packaging costs evolve.

The key takeaway from the quarter is that Jyothy Labs is protecting volumes and distribution momentum in a volatile cost environment, while using selective pricing and mix improvement to stabilise profitability. The company’s ability to sustain Fabric Care traction, keep Dishwash competitive without further realization erosion, and complete the HI profitability journey will be central to the FY27 earnings trajectory.